Determine your plan now for serialization readiness to put the worries of DSCSA costs and timelines behind you and patient safety back where it belongs — at the forefront.
Despite the benefits of B/F/S over glass, some pharmaceutical companies refuse to make the switch because of a number of objections.
As the biologics market continues to grow exponentially, the limitations of today’s thermal packaging utilizing phase change materials could have a considerable impact on the timely delivery of safe and effective medication. Gelled PCM eliminate these limitations and offer a more dependable future for the biopharma industry.
Although the European marketplace presents a significant opportunity for innovative orphan drug companies to meet unmet patient needs, launching your drug product can present a real challenge if you are not familiar with country specific requirements. Read more about Understanding and delivering your EU Orphan Drug Launch
Insights on how patient-centric options are extending to clinical trial design, with sponsors considering how clinical trial materials can be formulated, packaged, and delivered in a manner that is efficacious.
Cold is undeniably the new normal for the biopharmaceutical industry. By 2020, greater than half of bestselling drugs will be cold-chain products, most of which are injectable.
This latest evolution of HVLD aims to achieve a high level of closed container integrity (CCI) assurance across the entire range of parenteral products.
If the appearance and performance of your product’s packaging isn’t providing a positive experience for your customer, you may want to consider engaging a packaging consultant to work with your team.
Has laser coding reached its limits? No. This paper provides evidence and demonstrates that there is still huge potential for laser coding to remain the ideal choice in the pharmaceutical sector.
Item-level serialization gives each box or bottle of medication its own identity. This can be tracked at every stage of the supply chain – from the production line to the pharmacy and right through to the patient. This enhances the sense of ownership you have with your products, a marker of authenticity that verifies the quality of the contents. Any queries or complaints from pharmacy staff, medical professionals or patients can be traced right back to the individual box.
|
|
|
|
|
|
|
|
|